Cellectis SA (LTS:0WA2)
€ 1.474 0 (0%) Market Cap: 148.14 Mil Enterprise Value: -14.65 Mil PE Ratio: 0 PB Ratio: 1.29 GF Score: 60/100

Q2 2020 Cellectis SA Earnings Call Transcript

Aug 06, 2020 / 11:30AM GMT
Release Date Price: €14.54 (-0.95%)
Operator

Greetings, and welcome to the Cellectis Second Quarter Earnings Call. (Operator Instructions) As a reminder, this conference is being recorded.

It is now my pleasure to introduce your host, Simon Harnest. Thank you. You may begin.

Simon Harnest
Cellectis S.A. - VP of Corporate Strategy & Finance

Thank you, and welcome, everyone, to Cellectis Second Quarter 2020 Corporate Update and Financial Results Conference Call. Joining me on the call today with prepared remarks are Dr. André Choulika, our Chairman and Chief Executive Officer; Dr. Carrie Brownstein, our Chief Medical Officer; and Eric Dutang, our Chief Financial Officer.

Yesterday evening, Cellectis issued a press release reporting our financial results for the second quarter ended June 30, 2020. The press release is available on our website at cellectis.com.

As a quick reminder, we will make forward-looking statements regarding financial outlook in addition to regulatory and product development plans. These statements are subject to risks and uncertainties that may cause

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot